Department of Ophthalmology, Faculty of Medicine, Prince of Songkla University, 15 Karnjanavanich Rd, Hat Yai, Songkhla, 90110, Thailand.
Sci Rep. 2022 Jul 22;12(1):12553. doi: 10.1038/s41598-022-16780-5.
To describe the clinical features, longitudinal pattern, and incidence rate of improvement of visual acuity (VA) following antibiotic therapy in patients with syphilitic uveitis. A total of 36 patients were included in this retrospective study from 2009 to 2020. The longitudinal patterns of mean VA values during follow-up were analyzed using a linear mixed model. Most patients were men with HIV coinfection (81%) and presented with panuveitis (49%). The mean VA at baseline improved from 0.97 to 0.39 logMAR at 6 months and remained stable thereafter. The cumulative incidence of VA ≥ 20/25 achieved by 2 years was 70%. Receiving antibiotic therapy within four weeks of the onset of ocular symptoms (adjusted hazard ratio [aHR] 3.4, P = 0.012), absence of HIV coinfection (aHR 8.2, P < 0.001), absence of neurosyphilis (aHR 6.5, P = 0.037), better presenting VA (aHR 5.0, P = 0.003), and intermediate uveitis as opposed to panuveitis (aHR 11.5, P = 0.013) were predictive of achieving VA ≥ 20/25. Men with HIV coinfection represented the majority of our patients. Visual outcomes, in response to antibiotics, were favorable. Delayed treatment, poor presenting VA, presence of HIV coinfection, and concomitant neurosyphilis decreased the likelihood of VA restoration.
描述梅毒性葡萄膜炎患者接受抗生素治疗后视力(VA)改善的临床特征、纵向模式和发生率。本回顾性研究纳入了 2009 年至 2020 年期间的 36 例患者。使用线性混合模型分析随访期间平均 VA 值的纵向变化模式。大多数患者为男性,伴有 HIV 合并感染(81%),表现为全葡萄膜炎(49%)。基线时的平均 VA 从 0.97 提高到 6 个月时的 0.39 logMAR,此后保持稳定。2 年内 VA≥20/25 的累积发生率为 70%。在眼部症状出现后 4 周内接受抗生素治疗(校正后的危险比 [aHR] 3.4,P=0.012)、无 HIV 合并感染(aHR 8.2,P<0.001)、无神经梅毒(aHR 6.5,P=0.037)、更好的初始 VA(aHR 5.0,P=0.003)和中间葡萄膜炎而非全葡萄膜炎(aHR 11.5,P=0.013)与达到 VA≥20/25 相关。合并 HIV 感染的男性是我们患者中的大多数。对抗生素的反应,视力结果是有利的。治疗延迟、初始 VA 较差、存在 HIV 合并感染和同时伴有神经梅毒会降低 VA 恢复的可能性。